BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15996209)

  • 1. Rare SP-A alleles and the SP-A1-6A(4) allele associate with risk for lung carcinoma.
    Seifart C; Lin HM; Seifart U; Plagens A; DiAngelo S; von Wichert P; Floros J
    Clin Genet; 2005 Aug; 68(2):128-36. PubMed ID: 15996209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients.
    Gautschi O; Hugli B; Ziegler A; Bigosch C; Bowers NL; Ratschiller D; Jermann M; Stahel RA; Heighway J; Betticher DC
    Lung Cancer; 2006 Mar; 51(3):303-11. PubMed ID: 16406195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic susceptibility associated with rare HRAS1 variable number of tandem repeats alleles in Spanish non-small cell lung cancer patients.
    Rosell R; Calvo R; Sánchez JJ; Maurel J; Guillot M; Monzó M; Núñez L; Barnadas A
    Clin Cancer Res; 1999 Jul; 5(7):1849-54. PubMed ID: 10430091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surfactant protein A gene deletion and prognostics for patients with stage I non-small cell lung cancer.
    Jiang F; Caraway NP; Nebiyou Bekele B; Zhang HZ; Khanna A; Wang H; Li R; Fernandez RL; Zaidi TM; Johnston DA; Katz RL
    Clin Cancer Res; 2005 Aug; 11(15):5417-24. PubMed ID: 16061856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transcriptional activity of surfactant-apoproteins A1 and A2 in non small cell lung carcinomas and tumor-free lung tissues].
    Stoffers M; Goldmann T; Branscheid D; Galle J; Vollmer E
    Pneumologie; 2004 Jun; 58(6):395-9. PubMed ID: 15216431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphism of the binding domain of surfactant protein-A2 increases susceptibility to meningococcal disease.
    Jack DL; Cole J; Naylor SC; Borrow R; Kaczmarski EB; Klein NJ; Read RC
    Clin Infect Dis; 2006 Dec; 43(11):1426-33. PubMed ID: 17083016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer.
    Shih CM; Lee YL; Chiou HL; Chen W; Chang GC; Chou MC; Lin LY
    Lung Cancer; 2006 Apr; 52(1):15-20. PubMed ID: 16476505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of one-carbon metabolism-related gene polymorphisms on risk of lung cancer in Japan: a case control study.
    Suzuki T; Matsuo K; Hiraki A; Saito T; Sato S; Yatabe Y; Mitsudomi T; Hida T; Ueda R; Tajima K
    Carcinogenesis; 2007 Aug; 28(8):1718-25. PubMed ID: 17468511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor genotypes, haplotypes, gender, and the risk of non-small cell lung cancer.
    Zhai R; Liu G; Zhou W; Su L; Heist RS; Lynch TJ; Wain JC; Asomaning K; Lin X; Christiani DC
    Clin Cancer Res; 2008 Jan; 14(2):612-7. PubMed ID: 18223238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 3' UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer.
    Kotsinas A; Evangelou K; Sideridou M; Kotzamanis G; Constantinides C; Zavras AI; Douglass CW; Papavassiliou AG; Gorgoulis VG
    Cancer Lett; 2008 Feb; 259(2):177-85. PubMed ID: 18037232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism.
    Szymanowska A; Jassem E; Dziadziuszko R; Borg A; Limon J; Kobierska-Gulida G; Rzyman W; Jassem J
    Lung Cancer; 2006 Apr; 52(1):9-14. PubMed ID: 16499995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphism of CYP2D6 and lung cancer risk.
    Shaw GL; Falk RT; Frame JN; Weiffenbach B; Nesbitt JC; Pass HI; Caporaso NE; Moir DT; Tucker MA
    Cancer Epidemiol Biomarkers Prev; 1998 Mar; 7(3):215-9. PubMed ID: 9521436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfactant protein B gene variations and susceptibility to lung cancer in chromate workers.
    Ewis AA; Kondo K; Dang F; Nakahori Y; Shinohara Y; Ishikawa M; Baba Y
    Am J Ind Med; 2006 May; 49(5):367-73. PubMed ID: 16570259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Allelotyping the Hras1 minisatellite: formation of carcinogenic risk groups and predicting the course of non-small cell lung cancer].
    Chizhikov VV; Gaspar'ian AV; Zborovskaia IB
    Genetika; 2001 Oct; 37(10):1388-95. PubMed ID: 11761616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation markers of surfactant proteins in lung cancer.
    Lin Z; Thomas NJ; Bibikova M; Seifart C; Wang Y; Guo X; Wang G; Vollmer E; Goldmann T; Garcia EW; Zhou L; Fan JB; Floros J
    Int J Oncol; 2007 Jul; 31(1):181-91. PubMed ID: 17549420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in the two helicases ERCC2/XPD and ERCC3/XPB of the transcription factor IIH complex and risk of lung cancer: a case-control analysis in a Chinese population.
    Hu Z; Xu L; Shao M; Yuan J; Wang Y; Wang F; Yuan W; Qian J; Ma H; Wang Y; Liu H; Chen W; Yang L; Jing G; Huo X; Chen F; Jin L; Wei Q; Wu T; Lu D; Huang W; Shen H
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1336-40. PubMed ID: 16835333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of functional excision repair cross-complementation group 1 variants and their association with lung cancer risk and prognosis.
    Yu D; Zhang X; Liu J; Yuan P; Tan W; Guo Y; Sun T; Zhao D; Yang M; Liu J; Xu B; Lin D
    Clin Cancer Res; 2008 May; 14(9):2878-86. PubMed ID: 18451256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462Val polymorphism.
    Larsen JE; Colosimo ML; Yang IA; Bowman R; Zimmerman PV; Fong KM
    Cancer Causes Control; 2005 Jun; 16(5):579-85. PubMed ID: 15986113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in TGF-beta1 gene and the risk of lung cancer.
    Kang HG; Chae MH; Park JM; Kim EJ; Park JH; Kam S; Cha SI; Kim CH; Park RW; Park SH; Kim YL; Kim IS; Jung TH; Park JY
    Lung Cancer; 2006 Apr; 52(1):1-7. PubMed ID: 16499994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allele 2 of the interleukin-1 receptor antagonist gene (IL1RN*2) is associated with a decreased risk of primary lung cancer.
    Hu Z; Shao M; Chen Y; Zhou J; Qian J; Xu L; Ma H; Wang X; Xu Y; Lu D; Shen H
    Cancer Lett; 2006 May; 236(2):269-75. PubMed ID: 16019127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.